Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05337293 · ClinicalTrials.gov registry record · NA

Coping in Heart Failure Partnership Intervention

A NA study, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
106
Enrollment target

NCT05337293: Completed NA study, sponsored by Florida State University.

NCT05337293 is a NA study that has completed, run by Florida State University. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05337293, a NA study, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target

Study Summary

The purpose of this study is to examine the feasibility and preliminary effectiveness of a 12-week support and problem-solving telephone-based intervention (COPE-HF) on heart failure self-care, depression, and healthcare utilization. Heart failure patients will be randomized to one of three groups (intervention, attention, control), with data collected at baseline and at 5, 9, and 13 weeks.

Primary Outcome

Self-care maintenance was self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to treatment adherence and self-monitoring. Scores are standardized (0-100), with higher scores suggesting better self-care maintenance. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.

Interventions

  • BEHAVIORAL COPE-HF Partnership Intervention
  • OTHER Attention

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2015-03
Est. Completion 2016-08
Phase NA
Florida State University

219 total trials

What the finished NCT05337293 record still lists

NCT05337293 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which COPE-HF Partnership Intervention is the first listed.

NCT05337293 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05337293 about?

NCT05337293 is a clinical study titled "Coping in Heart Failure Partnership Intervention". The purpose of this study is to examine the feasibility and preliminary effectiveness of a 12-week support and problem-solving telephone-based intervention (COPE-HF) on heart failure self-care, depression, and healthcare utilization. Heart failure patients will be randomized to one of three groups (...

What is the current status of trial NCT05337293?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2015-03. Estimated completion is 2016-08.

What interventions are being tested in trial NCT05337293?

The interventions under investigation include: COPE-HF Partnership Intervention (BEHAVIORAL), Attention (OTHER).

Who is sponsoring clinical trial NCT05337293?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05337293's enrollment target sits among peer trials

106 830th of 2000 higher than 1,167 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT05337293, the US trial registry maintained by the National Library of Medicine. NCT05337293 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.